Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Medtronic
Covington
Baxter
AstraZeneca
Daiichi Sankyo
Deloitte
Queensland Health
UBS

Generated: June 25, 2018

DrugPatentWatch Database Preview

VERILOID Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Veriloid patents expire, and when can generic versions of Veriloid launch?

Veriloid is a drug marketed by 3M and is included in one NDA.

The generic ingredient in VERILOID is alkavervir. Additional details are available on the alkavervir profile page.
Summary for VERILOID
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 59
Formulation / Manufacturing:see details
DailyMed Link:VERILOID at DailyMed
Drug patent expirations by year for VERILOID

US Patents and Regulatory Information for VERILOID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m VERILOID alkavervir TABLET;ORAL 007336-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
3m VERILOID alkavervir TABLET;ORAL 007336-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Colorcon
Moodys
Accenture
Chubb
Express Scripts
AstraZeneca
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.